Strategic Advisors

Alissar has a unique ability to coordinate clinical, technical, and business teams, to quickly identify resistance to change and address through clear, compassionate communication. She has led and consulted across the healthcare industry, including nonprofits, businesses, hospital systems, payors, and Fortune 500 companies. She is passionate about identifying and fixing inefficiencies in the healthcare system to create a more human-centered experience.  

Jeff is a results-oriented leader in value-based care, healthcare strategy, and business development. He is known for building trusted relationships with national and regional health plan executives across the U.S. Innovative thinking and championing positive change have been consistent threads throughout his career.  

Andrew is a practicing physician and experienced startup advisor in home care, chronic care management, and digital health. An expert on hospital-to-home transitions, he has written on the subject as a contributor to The Hill and Associate Fellow at Wharton's Leonard Davis Institute. He holds a faculty position at Harvard Medical School and practices anesthesiology at Brigham & Women's Hospital in Boston, MA.  

Jerry’s experience in healthcare, AI-driven product development and enterprise transformation, paired with a commitment to improve patient care outcomes and experience. He is skilled at helping teams adopt a digital mindset and identifying when upskilling is needed. He focuses on ensuring new ideas that deliver value and fit into the realities of day-to-day work.  

Ravi has extensive experience in cloud architecture and financial operations, serving as a Fractional CTO, CFO, and COO. He has built scalable multi-cloud infrastructure and FinOps frameworks across health tech, AI, and enterprise ecosystems. He specializes in SaaS financial modeling, cloud and go-to-market strategy, and cost optimization. His track record of extending runway and hitting operational milestones reflects his focus on translating technical vision into commercial viability.